Bluepha Completes ￥40M Series A Financing, Focusing on Synthetic Biology

According to PEdaily.com, Bluepha has completed Series A financing of 40 million yuan, with participation from Zhongguancun Development Start Fund, Zhongguancun Development Frontier Fund, and Shenzhen Qianhai Fof. The existing shareholder FreesFund also participated in this financing, and Tanzhen Capital acted as the exclusive financial advisor. 

Proceeds will mainly be used for the industrialization of existing product pipelines, the research and development cooperation among many Fortune 500 enterprises, and the construction of gene elements technology platform.

Previously, Bluepha has signed a strategic cooperation agreement with state-owned chemical company Sinochem International in Tsinghua University on October 28, 2019. They will jointly promote the industrialization of the existing product pipeline of Bluepha, the bio-based degradable material-PHA (a kind of natural bio-polymer synthesized by microorganisms existing in nature, which can be made into various plastic products).

Established in 2016, Bluepha has completed several rounds of financing, bringing the total capital to tens of millions of yuan. The company has a unique gene elements technology platform, which meets the need for molecular and material innovation in the medical, environmental protection and consumer fields, opening the global market with hundreds of billions of dollars.

Bluepha is the first synbio startup founded by iGEMers in the Chinese iGEM (International Genetically Engineering Machine Competition) community. With the power of synthetic biology, the company enables the precise design of microorganism nano-factory to achieved the whole manufacturing processes under a microscope. 

Since its foundation in 2010, ZGC Group has been committed to building an open and shared ecosystem that integrates key factors of innovation. It deploys innovative resources across the world to promote the transformation and industrialization of scientific and technological achievements by means of establishing high-tech parks, making investments, providing finance and professional services. 

FreesFund mainly invests in early-stage and early growth-stage startups since 2015. It focuses on 2 fields - Retail and Deep Tech, and several industries such as Education, Fintech, A.I., Biotech and Pharmaceuticals, New Energy, Industry 4.0 and more. FreesFund provides services like business development, financial consultant, legal consultant, HR, PR, FA to its portfolio companies.